Können Bisphosphonat-Patienten bei Denis-Focus Dental behandelt werden?

Für Bisphosphonat-Patienten kann Denis-Focus Dental keine chirurgischen Eingriffe und keine Zahnextraktionen durchführen. Das Risiko einer Bisphosphonat-assoziierten Kiefernekrose ist zu hoch. Für Betroffene empfehlen wir eine gründliche Untersuchung und Behandlung in der Universitätsklinik Wien (AKH).

Was ist eine Bisphosphonat-assoziierte Kiefernekrose?

Die Bisphosphonat-induzierte Kiefernekrose ist eine ernste Nebenwirkung, die nach chirurgischen Eingriffen oder Zahnextraktionen bei Patienten unter Bisphosphonat-Therapie auftreten kann. Sie äußert sich durch Weichteilschwellung, Zahnlockerungen oder freiliegenden Kieferknochen.

Bei welchen Erkrankungen werden Bisphosphonate eingesetzt?

Bisphosphonate werden eingesetzt bei Skelettmetastasen, tumorinduzierter Hyperkalzämie, Osteoporose, Kalziumstoffwechselkrankheiten (Hyperparathyreoidismus), Morbus Paget und in der Schmerztherapie.

Home Treatments Important notesInformation for bisphosphonate patients

Bisphosphonat-Patienten Zahnbehandlung – Denis-Focus Dental Information

Patient Information - Bisphosphonate - Denis-Focus Dental

Information for
Bisphosphonate patients –
Important risk warning.

Important information for patients under Bisphosphonate therapy Please read this page carefully before scheduling a treatment appointment.

⚠️

Important note: For bisphosphonate patients, Denis-Focus Dental no surgical procedures and no tooth extractions carry out. We recommend thorough examination and treatment for those affected in the University Hospital Vienna (AKH).

Bisphosphonate Patients and Dental Treatment - What You Need to Know

Your doctor (rheumatologist) is treating you with a highly effective medication from the group of Bisphosphonate. These medications are used for various conditions – however, they carry significant risk potential during dental procedures.

Osteoporosis is fundamentally a risk factor for dental treatments, especially for oral surgery procedures and tooth extractions. This risk is increased by bisphosphonate medications, particularly intravenous injections. After treatments, they can cause bone lesions and Avonecrosis cause. According to German Dental Association Bisphosphonate patients must be particularly carefully informed and cared for before dental procedures.

Bisphosphonat-Patienten Information Denis-Focus Dental

Fields of application

Bisphosphonates are used for which diseases?

🦴Skeletal metastases

🔬Tumor-induced hypercalcemia

💊Osteoporosis

Alchemical JarHyperparathyroidism

🩺Paget's disease

💉Pain therapy

Risk profile

Bisphosphonate-associated osteonecrosis of the jaw – what is it?

Although the side effect profile of bisphosphonates has been considered favorable for years, since 2003 there has been an increasing number of cases in which Bisphosphonate-induced osteonecrosis of the jaw occurred under bisphosphonate medication. There is a particularly high risk for patients who, due to an underlying malignant disease Intravenous BP medication receive or have received.

This disease pattern initially manifests with the following symptoms:

Symptoms of bisphosphonate-associated osteonecrosis of the jaw:

Soft tissue swelling in the oral cavity
Tooth loosening
Exposed jawbone sites

Our recommendation

Bisphosphonate Patients: What Denis-Focus Dental Recommends

For Bisphosphonate patients Denis-Focus Dental cannot perform surgical procedures or tooth extractions. Our goal is always the best possible care for our patients – therefore, we cannot take this risk.

Our recommendation: For those affected who are undergoing or are about to start bisphosphonate therapy, we recommend thorough examination and treatment in the University Hospital Vienna (AKH). Please also speak with your treating physician (rheumatologist/internist) before making a dental appointment.

Frequently asked questions

Frequently Asked Questions About Bisphosphonate Patients and Dental Treatment

For Bisphosphonate patients Denis-Focus Dental cannot perform surgical procedures or tooth extractions. The risk of bisphosphonate-associated osteonecrosis of the jaw is too high. For affected individuals, we recommend treatment at the University Hospital Vienna (AKH).

The Bisphosphonate-induced osteonecrosis of the jaw is a serious side effect that can occur after surgical procedures or tooth extractions in patients undergoing bisphosphonate therapy. It manifests as soft tissue swelling, loose teeth, or exposed jawbone.

Bisphosphonate are used for bone metastases, tumor-induced hypercalcemia, osteoporosis, calcium metabolism disorders (hyperparathyroidism), Paget's disease, and pain therapy.

Questions about your treatment?
We advise you free of charge.

If you are unsure whether your medication affects dental treatment, please contact us. We will assist you.

Information forBisphosphonate patients –Important risk warning.